A 3-year-old Chris Delemater smothers his aunt, Jenn Powell, on the couch, along with Toby the dog. (Photos courtesy of Jenn Powell) Day 25 of 31 This is Chris Delemater’s story: What is it like to know someone with multiple sclerosis (MS)? Have I learned anything from someone…
disease progression
Treatment with Tysabri (natalizumab) may help delay disability progression in people with secondary progressive multiple sclerosis (SPMS) over Rebif (interferon beta-1a), an analysis of data from two clinical trials suggests. While the trials initially failed to demonstrate slowing disease progression, a significant benefit was observed when accounting…
Ena Salcinovic celebrates her birthday three years after her MS diagnosis. (Photos courtesy of Ena Salcinovic) Day 22 of 31 This is Ena Salcinovic’s story: Saturday. Finally. A good day. I still believe that even though I overslept and missed the Red Cross and our weekly international cooking. I…
Kevin Byrne grew up in Bronx, New York. A graduate of the U.S. Military Academy at West Point, he was struck by multiple sclerosis (MS) in 1999 while commanding an Army Air Cavalry Troop overseas. Now medically retired, he lives with his daughter, Rogue, in Portland, Oregon. Kevin works…
Starting Tysabri (natalizumab) early in multiple sclerosis (MS) treatment may lead to better outcomes, including greater reductions in relapse rates and less use of MS-related healthcare services over starting it after other therapies. That’s according to a U.S. healthcare claims analysis of more than 1,500 adults with MS.
Evidence of neurological damage over time — known as dissemination in time, or DIT — may not be necessary to reach a diagnosis of multiple sclerosis (MS) for all patients, according to a report by U.K. researchers. Traditionally, an MS diagnosis would typically require both DIT and DIS,…
Cognitive impairment is common in people with multiple sclerosis (MS) who have not previously received treatment, affecting about 1 in 4 patients, and rates are particularly higher in those with secondary progressive MS (SPMS), a new study found. “The current study demonstrates that a significant portion of MS…
Ronald Harris shows off his new power wheelchair. (Photos courtesy of Ronald Harris) Day 17 of 31 This is Ronald Harris’ story: Harris is seen working from home, using a desk that accommodates his power chair. My journey with multiple sclerosis (MS) began with an unexpected diagnosis…
Tom Anderson, 67, was diagnosed with multiple sclerosis at about 30 years old. (Photos courtesy of Tom Anderson) Day 16 of 31 This is Tom Anderson’s story: I may be the dimmest star, but don’t get all hokey on me. There are lots of us. The following are the…
Nanette Lai locks eyes with her chihuahua Fanny. Lai says mutual gazing between humans and dogs can cause synchronization in areas of the brain. (Photos courtesy of Nanette Lai) Day 12 of 31 This is Nanette Lai’s story: My name is Nanette, and I have lived with relapsing-remitting…
Neurons, also called nerve cells, collected from brain lesions of people with multiple sclerosis (MS) were found to accumulate new genetic mutations at a significantly faster rate than healthy neurons did, according to a new report. The researchers also found that neurons in such lesions exhibited distinct mutation…
Black people with multiple sclerosis (MS) walk more slowly and cover shorter distances over a certain time period than white people with the disease, a study in the U.S. finds. While the differences were somewhat attenuated when other factors that may impact walking ability were considered, such as age,…
In people with multiple sclerosis (MS), lesions that get slowly bigger over time, potentially due to chronic inflammation, are associated with more myelin loss throughout the brain, a study found. Loss of myelin was observed in these slowly expanding lesions, in other types of lesions, and also in regions…
Disability progression independent of relapse activity, or PIRA, in the earliest stages of relapsing-remitting multiple sclerosis (RRMS) is associated with worsening quality of life, a study in Sweden shows. PIRA is a form of sustained disability worsening that occurs in the absence of multiple sclerosis (MS) relapses. While…
Naty Caez shares about her life with MS on Instagram. (Photos courtesy of Naty Caez) Day 9 of 31 This is Naty Caez’s story: In September 2024, I was diagnosed with multiple sclerosis (MS). Everyone’s diagnosis story is going to look a little different, but for me, it took…
People with multiple sclerosis (MS) who switch from a high- to a moderate-efficacy disease-modifying therapy (DMT) increase their risk of disease activity, especially younger adults and those having inflammatory disease activity before a switch, a study finds. Knowing these factors “can help guide future studies on deescalation,” researchers…
People with multiple sclerosis (MS) who eat more fish are significantly less likely to see confirmed disability progression and the greater the intake, the lower the progression risk, a study in Sweden finds. The dietary habits of patients were assessed at the time of their diagnosis and disability progression…
Note: This story was updated March 6, 2025, to clarify the specific disability measures and results assessed in each trial. Sanofi’s experimental BTK inhibitor tolebrutinib may be more effective at reducing the risk of disability accumulation in people with multiple sclerosis (MS) who have evidence of paramagnetic…
I’ve noticed a lot of people with multiple sclerosis (MS) report that their disease worsens in the summer months, with fatigue and heat intolerance as common complaints. Not me. I seem to thrive in warmer weather, and I enjoy going outside for the heat. Instead, I struggle in the…
Sanam Saeedi resolved not to allow a diagnosis of MS to determine the course her life could take. (Photos courtesy of Sanam Saeedi) Day 1 of 31 This is Sanam Saeedi’s story: For years, I lived with numbness and tingling in my toes, but dismissed it as a result…
Immune cells from people with multiple sclerosis (MS) exhibit distinct gene activity just before patients have a disease relapse, according to recent research. The observed immune perturbations, which are no longer observed by the time the relapse is actively underway, are consistent with the body’s response to a reactivation…
A statistical model that takes clinical and demographic factors into account could help guide treatment decisions in people with relapsing-remitting multiple sclerosis (RRMS) who haven’t yet started on a multiple sclerosis (MS) therapy, a study reports. “Our study offers a predictive tool that fulfills an unmet need for…
Over the past decade, diagnoses of multiple sclerosis (MS) in Finland have become faster and treatments now follow the latest evidence, with about five times as many patients receiving high-efficacy disease-modifying therapies (DMTs) as first-line options, a study finds. Drawing on registry data, researchers found that diagnoses are…
Using an implantable scaffold to collect immune cells in mice, researchers have gained insights into the immunological mechanisms driving primary progressive multiple sclerosis (PPMS). Based on the findings, the scientists developed a treatment strategy to block specific inflammatory molecules, which eased MS severity in the mouse model. The study,…
Using Ocrevus (ocrelizumab) as a first-line treatment for early-stage relapsing forms of multiple sclerosis (MS) is significantly better at delaying disease progression than starting with a less effective drug and switching to Ocrevus later. That’s according to nine years of data from the OPERA I (NCT01247324) and…
Relapsing-remitting multiple sclerosis (RRMS) patients with low educational attainment are more likely to delay the start of disease-modifying therapies (DMTs) after a diagnosis than those with a high educational status, a Danish study suggests. Educational status wasn’t significantly associated with diagnostic delays after the onset of symptoms,…
My husband and I are both considering early retirement. We’d discussed it for the past five years but hadn’t made any firm decisions. Last month, we decided that we needed to get serious about planning for it. We met with a financial adviser for retirement planning advice at our investment…
The rate of relapses in children with pediatric-onset multiple sclerosis (POMS) tends to increase around the time that menstruation begins, a new study reports. The findings suggest hormonal changes at the onset of puberty may trigger higher disease activity. The use of oral and infusion disease-modifying therapies (DMT)…
Smoking and obesity are both independently associated with faster disease progression in multiple sclerosis (MS), but when both risk factors are present together, a synergistic effect results in faster disease progression than can be explained by either alone. “Smoking and obesity significantly interacted to increase the risk of disability…
For women with multiple sclerosis (MS), disability starts to worsen significantly faster after menopause, according to a new study. “The study shows that menopause represents a unique factor in MS progression, even when we take into consideration the effects of aging,” Riley Bove, MD, study co-author at the University…